Profile data is unavailable for this security.
About the company
Everest Medicines Ltd is a China-based company principally engaged in the licensing, clinical development and commercialization of therapies to address critical unmet medical needs. The Company is focusing on the research and development of innovative drug candidate. The Company built a portfolio of promising clinical-stage drug candidates across oncology, immunology, cardio-renal disease and infectious disease. The Company mainly provides its products and services in Greater China and other emerging Asia Pacific markets.
- Revenue in HKD (TTM)135.79m
- Net income in HKD-910.60m
- Incorporated2017
- Employees432.00
- LocationEverest Medicines Ltd16/F., CITIC Pacific Plaza,1168 West Nanjing Road, JingAn DistrictSHANGHAI 200041ChinaCHN
- Websitehttps://www.everestmedicines.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consun Pharmaceutical Group Ltd | 2.79bn | 845.97m | 5.59bn | 3.13k | 6.46 | 1.42 | 6.00 | 2.00 | 1.06 | 1.06 | 3.49 | 4.82 | 0.4981 | 2.08 | 9.10 | 893,174.10 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 41.53 | 10.71 | 7.03 | 14.88 | 11.01 | -- | 18.43 |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.01bn | -58.25m | 5.69bn | 2.87k | -- | 1.19 | -- | 2.84 | -0.0063 | -0.0063 | 0.2158 | 0.5122 | 0.1572 | 0.8101 | 4.72 | 698,552.90 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.35 | -2.63 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| Ascentage Pharma Group International | 239.37m | -998.13m | 5.86bn | 583.00 | -- | 89.98 | -- | 24.49 | -3.53 | -3.53 | 0.8479 | 0.2245 | 0.0833 | 2.38 | 2.22 | 410,580.30 | -34.73 | -44.93 | -52.82 | -57.04 | 86.24 | 87.68 | -417.02 | -976.10 | 1.42 | -15.03 | 0.9622 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
| Qyuns Therapeutics Co Ltd | 0.00 | -547.51m | 6.32bn | 331.00 | -- | 19.88 | -- | -- | -2.47 | -2.47 | 0.00 | 1.43 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.64 | -69.52 | 0.5349 | -- | -- | -- | -70.28 | -- | -- | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 872.61m | 110.19m | 6.46bn | 948.00 | 20.55 | 0.8961 | -- | 7.41 | 0.1071 | 0.1071 | 0.8287 | 2.45 | 0.2852 | 1.44 | 1.62 | 920,470.90 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
| New Horizon Health Ltd | 1.47bn | 119.29m | 6.47bn | 1.04k | 59.24 | 2.01 | 41.67 | 4.41 | 0.2387 | 0.2387 | 3.22 | 7.04 | 0.4536 | 2.16 | 2.08 | 1,672,716.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
| Tong Ren Tang Technologies Co Ltd | 7.30bn | 636.41m | 7.39bn | 4.10k | 11.61 | 0.9948 | 5.40 | 1.01 | 0.4969 | 0.4969 | 5.70 | 5.80 | 0.5212 | 0.9835 | 5.68 | 1,781,008.00 | 7.64 | 7.68 | 12.10 | 12.32 | 42.04 | 43.50 | 14.65 | 16.11 | 2.37 | -- | 0.1443 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | 0.0178 |
| China Shineway Pharmaceutical Group Ltd | 4.87bn | 1.05bn | 7.60bn | 3.44k | 6.64 | 1.00 | 6.21 | 1.56 | 1.38 | 1.38 | 6.45 | 9.17 | 0.5073 | 1.44 | 6.31 | 1,417,416.00 | 10.89 | 8.03 | 14.15 | 9.77 | 75.15 | 74.55 | 21.47 | 17.87 | 2.98 | -- | 0.0411 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Everest Medicines Ltd | 135.79m | -910.60m | 7.71bn | 432.00 | -- | 1.42 | -- | 56.79 | -2.91 | -2.91 | 0.4338 | 16.78 | 0.0203 | 2.25 | 4.57 | 314,338.30 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| Lepu Biopharma Co Ltd | 243.00m | -23.83m | 8.35bn | 429.00 | -- | 8.63 | 107.32 | 34.35 | -0.0144 | -0.0144 | 0.1464 | 0.5828 | 0.0917 | 1.06 | 1.62 | 566,433.70 | -1.23 | -- | -1.91 | -- | 87.45 | -- | -13.45 | -- | 0.7201 | 0.1388 | 0.4549 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
| Beijing Tong Ren Tang Chinese Medicine | 1.52bn | 540.39m | 8.59bn | 798.00 | 15.89 | 2.22 | 12.76 | 5.63 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 6.79bn | 2.15bn | 9.12bn | 4.62k | 4.24 | 1.07 | 3.76 | 1.34 | 2.44 | 2.44 | 7.71 | 9.72 | 0.5111 | 3.62 | 4.09 | 1,469,800.00 | 15.07 | 8.03 | 24.46 | 11.81 | 79.21 | 79.97 | 29.48 | 20.80 | 1.30 | 11.16 | 0.2475 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| Cansino Biologics Inc | 372.21m | -1.60bn | 9.13bn | 1.49k | -- | 0.9273 | -- | 24.54 | -6.48 | -6.48 | 1.51 | 23.02 | 0.0332 | 2.37 | 0.4619 | 249,139.40 | -18.93 | -4.27 | -26.69 | -5.60 | -253.78 | -- | -569.97 | -27.72 | 1.86 | -- | 0.3381 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
| AIM Vaccine Co Ltd | 1.28bn | -1.40bn | 9.20bn | 1.62k | -- | 2.34 | -- | 7.19 | -1.16 | -1.16 | 1.06 | 3.24 | -- | -- | -- | 788,462.10 | -- | -- | -- | -- | 75.88 | -- | -164.24 | -- | 0.7583 | -14.04 | 0.3158 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| InnoCare Pharma Ltd | 796.37m | -680.70m | 9.68bn | 1.09k | -- | 1.13 | -- | 12.16 | -0.4036 | -0.4036 | 0.4719 | 4.37 | 0.073 | 1.39 | 3.39 | 731,289.50 | -6.38 | -13.41 | -8.08 | -15.36 | 82.61 | 85.99 | -87.42 | -172.16 | 4.13 | -- | 0.1582 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
Data as of May 24 2024. Currency figures normalised to Everest Medicines Ltd's reporting currency: Hong Kong Dollar HKD
12.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Janchor Partners Ltd.as of 30 Sep 2023 | 15.88m | 4.90% |
| RA Capital Management LPas of 23 Nov 2022 | 15.22m | 4.70% |
| The Vanguard Group, Inc.as of 09 May 2024 | 3.81m | 1.17% |
| BlackRock Fund Advisorsas of 09 May 2024 | 2.35m | 0.73% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 1.20m | 0.37% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 1.15m | 0.36% |
| Wellington Management Co. LLPas of 27 Feb 2023 | 678.30k | 0.21% |
| BlackRock Advisors (UK) Ltd.as of 09 May 2024 | 440.50k | 0.14% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 439.50k | 0.14% |
| Charles Schwab Investment Management, Inc.as of 09 May 2024 | 200.72k | 0.06% |
More ▼
Data from 13 Nov 2023 - 16 May 2024Source: FactSet Research Systems Inc.
